학술논문

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax
Document Type
Article
Source
In: Haematologica. (Haematologica, October 2023, 108(10):2837-2843)
Subject
Language
English
ISSN
15928721
03906078